Graphite Bio Probability of Future Stock Price Finishing Under 2.89
| GRPHDelisted Stock | USD 2.67 0.05 1.84% |
Graphite |
Graphite Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Graphite Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Graphite Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Graphite Bio is now traded under the symbol LENZ. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Graphite Bio is not yet fully synchronised with the market data | |
| Graphite Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (124.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Graphite Bio currently holds about 322.29 M in cash with (90.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.54, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 84.0% of the company shares are owned by institutional investors |
Graphite Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Graphite Stock often depends not only on the future outlook of the current and potential Graphite Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Graphite Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57 M | |
| Cash And Short Term Investments | 185.9 M |
Graphite Bio Technical Analysis
Graphite Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Graphite Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Graphite Bio. In general, you should focus on analyzing Graphite Stock price patterns and their correlations with different microeconomic environments and drivers.
Graphite Bio Predictive Forecast Models
Graphite Bio's time-series forecasting models is one of many Graphite Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Graphite Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Graphite Bio
Checking the ongoing alerts about Graphite Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Graphite Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Graphite Bio is now traded under the symbol LENZ. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Graphite Bio is not yet fully synchronised with the market data | |
| Graphite Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (124.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Graphite Bio currently holds about 322.29 M in cash with (90.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.54, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 84.0% of the company shares are owned by institutional investors |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Graphite Stock
If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |